News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Johnson & Johnson to Develop Spider Venom Pain Drug With Queensland University
February 16, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Feb. 16 (Bloomberg) -- Johnson & Johnson and the University of Queensland will co-develop drugs using components of spider venom as a treatment for chronic pain.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Layoff Tracker
EMD Serono cuts 20 at Massachusetts research site
August 18, 2026
·
85 min read
·
BioSpace Editorial Staff
Manufacturing
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
August 18, 2026
·
2 min read
·
Nick Paul Taylor
Dermatology
LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug
August 18, 2026
·
1 min read
·
Annalee Armstrong
Manufacturing
Rebounding biotech funds expected to spur CDMO growth within year
August 18, 2026
·
2 min read
·
Nick Paul Taylor
